Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients

By Konjević Gordana   Mirjačić Martinović Katarina   Vuletić Ana   Jović Viktor   Jurisić Vladimir   Babović Nada   Spužić Ivan  

Clinical and Experimental Metastasis, Vol. 24, Iss. 1, 2007-03 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Transient activation of tumor-associated T-effector/memory cells promotes tumor eradication via NK-cell recruitment: minimal role for long-term T-cell immunity in cure of metastatic disease

By Gu Tao   Kilinc Mehmet   Egilmez Nejat  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 7, 2008-07 ,pp. : 997-1005

Springer Publishing Company

Access to resources Recommend Favorite

Tumour Cell Vaccines That Secrete Interleukin-2 (IL-2) and Interferon (IFN ) are Recognised by T Cells While Resisting Destruction by Natural Killer (NK) Cells

By Zier K.S.   Gansbacher B.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1408-1412

Elsevier

Access to resources Recommend Favorite

A phase I clinical trial of low-dose interferon-α-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma

By Amato Robert   Khan Muhammad  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 1069-1073

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic Outcome of Extranodal NK/T-Cell Lymphoma Initially Treated with Chemotherapy

By Kim Byung Su   Kim Tae-you   Kim Chul Woo   Kim Ji Yeun   Heo Dae Seog   Bang Yung-jue   Kim Noe Kyeong  

Acta Oncologica, Vol. 42, Iss. 7, 2003-11 ,pp. : 779-783

Informa Healthcare

Access to resources Recommend Favorite